• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于模型的对单核细胞和巨噬细胞在单克隆抗体药代动力学中作用的评估。

Model-Based Assessment of the Contribution of Monocytes and Macrophages to the Pharmacokinetics of Monoclonal Antibodies.

机构信息

School of Pharmacy, University of Waterloo, 10A Victoria St S, Kitchener, Ontario, N2G 1C5, Canada.

出版信息

Pharm Res. 2022 Feb;39(2):239-250. doi: 10.1007/s11095-022-03177-2. Epub 2022 Feb 3.

DOI:10.1007/s11095-022-03177-2
PMID:35118567
Abstract

PURPOSE

We have hypothesized that a high concentration of circulating monocytes and macrophages may contribute to the fast weight-based clearance of monoclonal antibodies (mAbs) in young children. Exploring this hypothesis, this work uses modeling to clarify the role of monocytes and macrophages in the elimination of mAbs.

METHODS

Leveraging pre-clinical data from mice, a minimal physiologically-based pharmacokinetic model was developed to characterize mAb uptake and FcRn-mediated recycling in circulating monocytes, macrophages, and endothelial cells. The model characterized IgG disposition in complex scenarios of site-specific FcRn deletion and variable endogenous IgG levels. Evaluation was performed for predicting IgG disposition with co-administration of high dose IVIG. A one-at-a-time sensitivity analysis quantified the role of relevant cellular parameters on IgG elimination in various scenarios.

RESULTS

The plasma AUC of mAbs was highly sensitive to endothelial cell parameters, but had near-nil sensitivity to monocyte and macrophage parameters, even in scenarios with 90% loss of FcRn expression/activity. In mice with normal FcRn expression, simulations suggest that less than 2% of an IV dose is eliminated in macrophages, while endothelial cells are predicted to dominate mAb elimination.

CONCLUSIONS

The model suggests that the role of monocytes and macrophages in IgG homeostasis includes extensive uptake and highly efficient FcRn-mediated protection, but not appreciable degradation when FcRn is present. Therefore, it is very unlikely that a high concentration of circulating monocytes can contribute to explaining the fast weight-based clearance of mAbs in very young children, even if FcRn expression/activity was 90% lower in children than in adults.

摘要

目的

我们假设循环单核细胞和巨噬细胞的高浓度可能有助于年幼儿童基于体重的单克隆抗体(mAb)快速清除。为了探索这一假设,本研究利用建模来阐明单核细胞和巨噬细胞在 mAb 消除中的作用。

方法

利用来自小鼠的临床前数据,开发了一个最小的基于生理的药代动力学模型,以描述 mAb 在循环单核细胞、巨噬细胞和内皮细胞中的摄取和 FcRn 介导的循环。该模型描述了在 FcRn 特异性缺失和可变内源性 IgG 水平的复杂情况下 IgG 的处置情况。通过评估与高剂量静脉注射免疫球蛋白(IVIG)联合给药时对 IgG 处置的预测,对模型进行了评估。逐个参数的敏感性分析量化了在各种情况下相关细胞参数对 IgG 消除的作用。

结果

mAb 的血浆 AUC 对内皮细胞参数高度敏感,但对单核细胞和巨噬细胞参数几乎没有敏感性,即使在 FcRn 表达/活性损失 90%的情况下也是如此。在具有正常 FcRn 表达的小鼠中,模拟表明少于 IV 剂量的 2%在巨噬细胞中消除,而内皮细胞被预测为主导 mAb 消除。

结论

该模型表明单核细胞和巨噬细胞在 IgG 动态平衡中的作用包括广泛摄取和高效的 FcRn 介导保护,但在 FcRn 存在时,不会明显降解。因此,即使儿童的 FcRn 表达/活性比成人低 90%,循环单核细胞的高浓度也不太可能有助于解释非常年幼儿童基于体重的 mAb 快速清除。

相似文献

1
Model-Based Assessment of the Contribution of Monocytes and Macrophages to the Pharmacokinetics of Monoclonal Antibodies.基于模型的对单核细胞和巨噬细胞在单克隆抗体药代动力学中作用的评估。
Pharm Res. 2022 Feb;39(2):239-250. doi: 10.1007/s11095-022-03177-2. Epub 2022 Feb 3.
2
Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human.建立一个 PBPK 平台模型以描述单克隆抗体在临床前物种和人体内的血浆和组织分布特征。
J Pharmacokinet Pharmacodyn. 2012 Feb;39(1):67-86. doi: 10.1007/s10928-011-9232-2. Epub 2011 Dec 6.
3
Physiologically-based pharmacokinetic (PBPK) model to predict IgG tissue kinetics in wild-type and FcRn-knockout mice.基于生理的药代动力学(PBPK)模型,用于预测野生型和FcRn基因敲除小鼠体内IgG的组织动力学。
J Pharmacokinet Pharmacodyn. 2007 Oct;34(5):687-709. doi: 10.1007/s10928-007-9065-1. Epub 2007 Jul 18.
4
Application of Physiologically Based Pharmacokinetic Modeling to Predict the Effects of FcRn Inhibitors in Mice, Rats, and Monkeys.生理药代动力学模型在预测 FcRn 抑制剂在小鼠、大鼠和猴子体内作用的应用。
J Pharm Sci. 2019 Jan;108(1):701-713. doi: 10.1016/j.xphs.2018.10.065. Epub 2018 Nov 10.
5
Neonatal Fc receptor expression in macrophages is indispensable for IgG homeostasis.新生儿 Fc 受体在巨噬细胞中的表达对于 IgG 的内稳态是必不可少的。
MAbs. 2019 Jul;11(5):848-860. doi: 10.1080/19420862.2019.1602459. Epub 2019 Apr 30.
6
Physiologically based pharmacokinetic (PBPK) model that describes enhanced FcRn-dependent distribution of monoclonal antibodies (mAbs) by pI-engineering in mice.基于生理学的药代动力学(PBPK)模型,该模型描述了通过小鼠中的等电点工程增强单克隆抗体(mAb)的FcRn依赖性分布。
Drug Metab Pharmacokinet. 2023 Dec;53:100506. doi: 10.1016/j.dmpk.2023.100506. Epub 2023 Mar 22.
7
Evaluation of a catenary PBPK model for predicting the in vivo disposition of mAbs engineered for high-affinity binding to FcRn.评估一个用于预测高亲和力结合 FcRn 的 mAbs 体内处置的悬链线 PBPK 模型。
AAPS J. 2012 Dec;14(4):850-9. doi: 10.1208/s12248-012-9395-9. Epub 2012 Sep 7.
8
Hematopoietic cells as site of first-pass catabolism after subcutaneous dosing and contributors to systemic clearance of a monoclonal antibody in mice.皮下给药后首过代谢的部位和影响小鼠体内单抗系统清除率的因素:造血细胞。
MAbs. 2018 Jul;10(5):803-813. doi: 10.1080/19420862.2018.1458808. Epub 2018 May 9.
9
Investigation of the role of FcγR and FcRn in mAb distribution to the brain.研究 FcγR 和 FcRn 在单抗向脑内分布中的作用。
Mol Pharm. 2013 May 6;10(5):1505-13. doi: 10.1021/mp300214k. Epub 2012 Aug 23.
10
Combined glyco- and protein-Fc engineering simultaneously enhance cytotoxicity and half-life of a therapeutic antibody.糖基化和蛋白质-Fc联合工程同时增强治疗性抗体的细胞毒性和半衰期。
MAbs. 2014 Mar-Apr;6(2):422-36. doi: 10.4161/mabs.27854. Epub 2014 Jan 15.

引用本文的文献

1
Mechanistic incorporation of FcRn binding in plasma and endosomes in a whole body PBPK model for large molecules.在大分子的全身 PBPK 模型中,FcRn 结合在血浆和内体中的机制性纳入。
J Pharmacokinet Pharmacodyn. 2023 Jun;50(3):229-241. doi: 10.1007/s10928-023-09849-9. Epub 2023 Mar 6.

本文引用的文献

1
Characterization of glycosylation in monoclonal antibodies and its importance in therapeutic antibody development.单克隆抗体糖基化的表征及其在治疗性抗体开发中的重要性。
Crit Rev Biotechnol. 2021 Mar;41(2):300-315. doi: 10.1080/07388551.2020.1869684. Epub 2021 Jan 11.
2
Balancing the Affinity and Pharmacokinetics of Antibodies by Modulating the Size of Charge Patches on Complementarity-Determining Regions.通过调节互补决定区电荷斑的大小来平衡抗体的亲和力和药代动力学。
J Pharm Sci. 2020 Dec;109(12):3690-3696. doi: 10.1016/j.xphs.2020.09.003. Epub 2020 Sep 7.
3
Whole-Body Pharmacokinetics of Antibody in Mice Determined using Enzyme-Linked Immunosorbent Assay and Derivation of Tissue Interstitial Concentrations.
使用酶联免疫吸附测定法测定小鼠体内抗体的全身药代动力学及组织间隙浓度的推导。
J Pharm Sci. 2021 Jan;110(1):446-457. doi: 10.1016/j.xphs.2020.05.025. Epub 2020 Jun 2.
4
Integration of Ontogeny Into a Physiologically Based Pharmacokinetic Model for Monoclonal Antibodies in Premature Infants.将个体发育纳入早产儿单克隆抗体生理基于药代动力学模型中。
J Clin Pharmacol. 2020 Apr;60(4):466-476. doi: 10.1002/jcph.1540. Epub 2019 Nov 14.
5
Neonatal Fc receptor expression in macrophages is indispensable for IgG homeostasis.新生儿 Fc 受体在巨噬细胞中的表达对于 IgG 的内稳态是必不可少的。
MAbs. 2019 Jul;11(5):848-860. doi: 10.1080/19420862.2019.1602459. Epub 2019 Apr 30.
6
Application of Physiologically Based Pharmacokinetic Modeling to Predict the Effects of FcRn Inhibitors in Mice, Rats, and Monkeys.生理药代动力学模型在预测 FcRn 抑制剂在小鼠、大鼠和猴子体内作用的应用。
J Pharm Sci. 2019 Jan;108(1):701-713. doi: 10.1016/j.xphs.2018.10.065. Epub 2018 Nov 10.
7
Pediatric physiology in relation to the pharmacokinetics of monoclonal antibodies.儿科生理学与单克隆抗体药代动力学的关系。
Expert Opin Drug Metab Toxicol. 2018 Jun;14(6):585-599. doi: 10.1080/17425255.2018.1482278. Epub 2018 Jun 4.
8
Hematopoietic cells as site of first-pass catabolism after subcutaneous dosing and contributors to systemic clearance of a monoclonal antibody in mice.皮下给药后首过代谢的部位和影响小鼠体内单抗系统清除率的因素:造血细胞。
MAbs. 2018 Jul;10(5):803-813. doi: 10.1080/19420862.2018.1458808. Epub 2018 May 9.
9
A generic whole body physiologically based pharmacokinetic model for therapeutic proteins in PK-Sim.PK-Sim 中治疗性蛋白的通用全身生理药代动力学模型。
J Pharmacokinet Pharmacodyn. 2018 Apr;45(2):235-257. doi: 10.1007/s10928-017-9559-4. Epub 2017 Dec 12.
10
Quantification of IgG monoclonal antibody clearance in tissues.组织中IgG单克隆抗体清除率的定量分析。
MAbs. 2017 Aug/Sep;9(6):1007-1015. doi: 10.1080/19420862.2017.1337619. Epub 2017 Jun 14.